s of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, Poster no E96, New Orleans, Louisiana, USA, September 15–18. [34] Gruneberg RN, Hryniewicz W. Clinical relevance of a European Collaborative study on comparative susceptibility of gram positive clinical isolates to teicoplanin and vancomycin. Int J Antimicrob Agents 1998;10:271–7. [35] Papaparaskevas J, Stefanou J, Vatopoulos A, Thomopoulos G, Avlami A. The first clinical isolate of Enterococcus faecium with the VanB phenotype in a teaching hospital in Greece. Clin Microbiol Infect 1999;5:763–5. [36] Marcus N, Peled N, Yagupsky P. Rapid increase in the prevalence of antimicrobial drug resistance among enterococcal blood isolates in southern Israel. Eur J Clin Microbiol Infect Dis 1997;16:913–5. [37] Fontana R, Ligozzi M, Mazzariol A, Veneri G. The Italian Surveillance Group for Antimicrobial resistance, and Cornaglia G. Resistance of enterococci to ampicillin and glycopeptide antibiotics in Italy. Clin Infect Dis 1998;27(Suppl 1):84–6. [38] Fazii P, Calella G, Sforza R, Pizzigallo E. Antibiotic susceptibility of enterococci in a county of Italy. In abstracts of the 21st International Congress of Chemotherapy, Poster no 520, Birmingham, UK, 1999, July 4–7. [39] Sanches IS, Lencastre H. Bacterial resistance in Portugal. In: Abstracts of 9th Mediterranean Congress of Chemotherapy, Tels of 9th Mediterranean Congress of Chemotherapy, Tel Aviv, Israel, 1998, October 18–21, p. 70. [40] Betriu C, Palau L, Gomez M, Sanchez A, Romero J, Picazo JJ. Bacteremias in a university hospital: study of etiologic agents and their sensitivity patterns. Rev Clin Esp 1999;199:503–10. [41] Vural T, Sekercioglu AO, O8 ðunc D, Gultekin M, Colak D, Yeþilipek A, U8 nal S, Kocagoz S, Mutlu G. Vancomycin resistant Enterococcus faecium strain. J ANKEM 1999;13:1–4. [42] Gur D, Hascelik G, Kocagoz S, Miller GH, Sabatelli FJ, U8 nal S. Resistance phenotypes in enterococcus species in a Turkish hospital. In abstracts of 8th International Congress on Infectious Diseases, poster no. 47.014, Boston, USA, 1998, May 15–18. [43] Vincent JL. The EPIC Study: A European study of ICU infections. Presentation at the 13th International symposium on Intensive care and Emergency Medicine, Brussels, 1993, March 24. [44] Araj GF, Uwaydah MM, Alami SY. Antimicrobial susceptibility patterns of bacterial isolates at the American University Medical center in Lebanon. Diagn Microbiol Infect Dis 1994;20:151–8. [45] Melo-Cristino J. POSGAR. Portuguese Study Group of Antimicrobial Resistance. Antimicrobial resistance in staphylococci and enterococci in 10 Portuguese hospitals in 1996 and 1997. Microb Drug Resist 1998;4:319–24. [46] Cristino JM, Fernandez ML, Garcia T, Serrano N, Salgado MJ. The diversity of Staphylococcus aureus strains isolated in a Lisbon hospital over a 4-year period. Acta Med Port 1999;12:169–76. [47] Tsakris A, Douboyas J, Kyriakis K. Multidrug resistance among methicillin-resistant Staphylococcus aureus in Greece. J Chemother